Gaston Hematology and Oncology

Gastonia, North Carolina 28054

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Lung Cancer, Non-small-cell Lung Carcinoma, Prostate Cancer, Renal Cell Carcinoma

Studies at this site

• Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer — Stopped early
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
• A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma — Stopped early
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) — Stopped early